Teleflex Incorporated (TFX) is a publicly traded Healthcare sector company. As of May 20, 2026, TFX trades at $135.19 with a market cap of $5.77B and a P/E ratio of -5.91. TFX moved +1.90% today. Year to date, TFX is +8.61%; over the trailing twelve months it is +6.56%. Its 52-week range spans $100.18 to $249.91. Analyst consensus is buy with an average price target of $145.38. Rallies surfaces TFX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TFX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TFX recently traded at $135.19. Market cap is $5.77B. P/E ratio is -5.91. Revenue is $2.13B.
| Metric | Value |
|---|---|
| Price | $135.19 |
| Market Cap | $5.77B |
| P/E Ratio | -5.91 |
| EPS | $-22.80 |
| Dividend Yield | 0.34% |
| 52-Week High | $249.91 |
| 52-Week Low | $100.18 |
| Volume | 561.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.13B |
| Net Income | $-1.01B |
| Gross Margin | 55.14% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.99B | $-905.64M | $-20.30 |
| 2024 | $3.05B | $69.67M | $1.49 |
| 2023 | $2.97B | $356.33M | $7.58 |
| 2022 | $2.79B | $363.14M | $7.74 |
8 analysts cover TFX: 0 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.38.